|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400080707 |
|
最近更新日期: Date of Last Refreshed on: |
2024-02-05 11:42:12 |
|
注册时间: Date of Registration: |
2024-02-05 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
积极心理学视角下妊娠丢失夫妻心理健康现状及正念干预的效果研究 |
|
Public title: |
The status of mental health among the pregnancy loss couples and the effect of mindfulness intervention from the perspective of positive psychology |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
积极心理学视角下妊娠丢失夫妻心理健康现状及正念干预的效果研究 |
|
Scientific title: |
The status of mental health among the pregnancy loss couples and the effect of mindfulness intervention from the perspective of positive psychology |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张乐芸 |
研究负责人: |
张乐芸 |
|
Applicant: |
Leyun Zhang |
Study leader: |
Leyun Zhang |
|
申请注册联系人电话: Applicant telephone: |
+86 15937197580 |
研究负责人电话: Study leader's telephone: |
+86 15937197580 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1752031437@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1752031437@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
福建省厦门市思明区镇海路10号 |
研究负责人通讯地址: |
厦门市镇海路10号 |
|
Applicant address: |
10 Zhenhai Road, Siming District, Xiamen City, Fujian Province |
Study leader's address: |
No. 10, Zhenhai Road, Xiamen |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
厦门市妇幼保健院 |
||
|
Applicant's institution: |
Xiamen Maternal and Child Health Hospital |
||
|
研究负责人所在单位: |
厦门市妇幼保健院 |
||
|
Affiliation of the Leader: |
Xiamen Maternal and Child Care Hospital |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY-2023-149-H01 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
厦门市妇幼保健院人体研究伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Council of Human Research in Xiamen Maternal and Child Health Care Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-12-03 00:00:00 |
||
|
伦理委员会联系人: |
陈舒婷 |
||
|
Contact Name of the ethic committee: |
Chen ShuTing |
||
|
伦理委员会联系地址: |
厦门市镇海路10号 |
||
|
Contact Address of the ethic committee: |
No. 10, Zhenhai Road, Xiamen |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 592 2662041 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
znc101@163.com |
|
研究实施负责(组长)单位: |
厦门市妇幼保健院 |
||||||||||||||||||||||
|
Primary sponsor: |
Xiamen Maternal and Child Care Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
厦门市镇海路10号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 10, Zhenhai Road, Xiamen |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
厦门市自然科学基金青年项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Xiamen Municipal Natural Science Foundation Youth Project |
||||||||||||||||||||||
|
Target disease: |
pregnancy loss; miscarriage |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
项目将以积极心理学为指导,关注妊娠丢失女性及其配偶的心理健康,对妊娠丢失女性及其配偶开展以夫妻为中心的正念干预,并评价干预对夫妻双方的创伤后成长、夫妻关系质量、抑郁、焦虑的影响。 |
||||||||||||||||||||||
|
Objectives of Study: |
The project will be guided by positive psychology, focusing on the mental health of pregnancy loss women and their spouses. Couple centered mindfulness interventions will be carried out for pregnancy loss women and their spouses, and the effect of the intervention on the post-traumatic growth, quality of marital relationships, depression, and anxiety of both spouses will be evaluated. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
①年龄≥18岁; |
||||||||||||||||||||||
|
Inclusion criteria |
①Age ≥18 years |
||||||||||||||||||||||
|
排除标准: |
①并发其他重大疾病者,如心功能衰竭、呼吸功能衰竭、恶性肿瘤、严重外伤等其他危重病症者; |
||||||||||||||||||||||
|
Exclusion criteria: |
① Patients complicated with other serious diseases, such as heart failure, respiratory failure, malignant tumor, severe trauma and other critical diseases |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2023-07-01 00:00:00至 To 2026-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-02-20 00:00:00 至 To 2025-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由研究者采用随机数字表法生成随机数列。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random sequence was generated by the researcher using a random number table. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
开放标签 |
|
Blinding: |
Open-label study |
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
unshared |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
研究者使用问卷星进行调查问卷的收集,将所有数据录入EpiData,采用IBM SPSS21.0对数据进行整理。 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Researchers used QuestionStar to collect survey questionnaires, entered all data into EpiData, and organized the data using IBM SPSS 21.0. |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |